Despite the potential of GLP-1RA plus SGLT2i combination therapy to improve metabolic-cardiovascular-renal trajectories, several factors may delay this combination to become a common practice soon, and most T2DM patients with ASCVD or at high ASCVD risk remain inadequately managed
One large study found that semaglutide use was associated with improved joint outcomes, raising the possibility of a disease-modifying effect
They follow the news, seek out updates, and query their physicians for timelines
For the most effective symptom relief, its important to take antimigraine prescription medications and OTC pain relievers as directed and to follow your healthcare provider's instructions
However, women managing both conditions need more frequent monitoring and may need coordinated care between endocrinology and gynecology
Most studies have reported that GLP-1RAs have renoprotective effects